Clinical Trial Update: Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis [NA]

View source ↗

Summary

A terminated clinical trial evaluated the efficacy and tolerability of Deucravacitinib in palmoplantar pustulosis, sponsored by Peking University First Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Peking University First Hospital | Conditions: Palmoplantar Pustulosis | NA | Status: TERMINATED